Radboudumc and partners SPL Medical has signed an agreement with NanoEcho

28 February 2024

The business agreement, signed today by SPL Medical and NanoEcho, is a comprehensive contract. The agreement grants NanoEcho exclusivity regarding the supply of ferumoxtran (iron oxide-based nanoparticles) for use in magnetomotive ultrasound.

Learn more in the press release.

Related news items


Radboudumc Investment Day keeps growing

11 October 2024

Scientists, entrepreneurs and investors from the life sciences & health sector came together to exchange knowledge, network and talk about new collaborations.

go to page

Third Radboudumc Investment Day again well-attended

16 October 2023

On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.

go to page

Thirona Raises €7,5 Million New Financing

14 September 2023

Nijmegen, the Netherlands (September 11th, 2023) – Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial intelligence and Radboudumc spin-off, is thrilled to announce the successful completion of its new investment. 

go to page

Thirona awarded to receive EIC grant

30 June 2023

Following the second 2023 EIC Accelerator cut-off in March, Thirona is awarded to receive European Innovation Council (EIC) funding.

go to page

SPL Medical announces collaboration with NanoEcho for application of Ferrotran® (Ferumoxtran) for Ultrasound detection of Lymph node metastases

30 September 2022

SPL medical and NanoEcho have signed a Letter of Intent and initiated a cooperation on regulatory partnership and supply for SPL medical proprietary iron-based nanoparticle Ferrotran® (Ferumoxtran) product and platform.

go to page